For the year ending 2025-10-31, PBSV has $13,653,046 in assets. $1,738,799 in debts.
| Balance Sheets | 2025-10-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 3,379,212 | |||
| Marketable securities | 7,475,377 | |||
| Accounts receivable | 2,360,682 | |||
| Prepaids and other assets | 171,574 | |||
| Total current assets | 13,386,845 | |||
| Property and equipment | 116,059 | |||
| Operating lease right-of-use | 29,388 | |||
| Other assets | 120,754 | |||
| Total assets | 13,653,046 | |||
| Current operating lease liabilities | 28,834 | |||
| Accounts payable and accrued expenses | 991,169 | |||
| Current portion of us tcja transition tax and income taxes payable | 718,796 | |||
| Total current liabilities | 1,738,799 | |||
| Us tcja transition tax payable | 0 | |||
| Long term operating lease liabilities | 0 | |||
| Total liabilities | 1,738,799 | |||
| Common stock, 0.0001 par value authorized 50,000,000 shares 23,519,672 and 23,519,672 shares issued, and 22,905,992 and 22,958,143 shares outstanding on october 31, 2025 and 2024, respectively | 2,352 | |||
| Additional paid-in capital | 1,679,547 | |||
| Retained earnings | 10,533,589 | |||
| Accumulated other comprehensive income | 278,045 | |||
| Stockholders equity before treasury stock | 12,493,533 | |||
| Treasury stock, at cost 613,680 and 561,529 common shares held on october 31, 2025 and 2024, respectively | 579,286 | |||
| Total stockholders' equity | 11,914,247 | |||
| Total liabilities and stockholders' equity | 13,653,046 | |||
Pharma-Bio Serv, Inc. (PBSV)
Pharma-Bio Serv, Inc. (PBSV)